US sues Regeneron, alleging false price reporting on Eylea
The Department of Justice accused Regeneron of defrauding Medicare by knowingly inflating the average sales price for its top-selling eye drug.
The Department of Justice accused Regeneron of defrauding Medicare by knowingly inflating the average sales price for its top-selling eye drug.
A Thursday board meeting among Massachusetts regulators shed more light on UnitedHealth’s proposed buy of Stewardship Health.
Congress has until year-end to take action before some pandemic-era telehealth flexibilities expire, which could create new challenges for patients and providers used to virtual care, witnesses at House hearing said.
One of the nation’s largest hospital landlords will pay down its debt load with the proceeds, executives said.
Regulators said payments to hospitals would increase $3.2 billion in 2025 under the proposed rule. However, the American Hospital Association called the hike “woefully inadequate.”
Former Centene executive Jim Murray will lead operations at the Walgreens-backed primary care chain, which has shut down 140 clinics in recent months.
The number of people enrolled in Medicaid soared over the pandemic, but many enrollees may not have known their coverage had continued, new research suggests.
Amy Perry, the current president, will take the reins from longtime chief executive Peter Fine beginning June 30.
Antitrust agencies could be sympathetic toward the deal, given Steward’s financial distress and important hospital portfolio. But sympathy won’t shield the deal from scrutiny, an expert told Healthcare Dive.
However, the insurers could protest Michigan’s decision, potentially mitigating membership erosion.